Institutional Ownership
Rapport Therapeutics Inc
CUSIP 75383L102COMRAPPQ1 2026
Institutional Holders
141
13F filers
Shares Held
50.60M
Aggregate institutional
Institutional Value
$1.54B
Q1 2026
Net New Holders
+1
23 new · 22 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions23
Increased53
Decreased34
Sold out22
Institutional Holders
141 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Fmr LLC | 7.17M | $224.32M | +57.1K | Added |
| 2 | Trv Gp V, LLC | 7.14M | $223.26M | 0 | Held |
| 3 | Arch Venture Management, LLC | 3.73M | $116.67M | 0 | Held |
| 4 | Capital International Investors | 3.10M | $96.94M | −304.6K | Reduced |
| 5 | Cormorant Asset Management, LP | 2.96M | $92.54M | −70.0K | Reduced |
| 6 | Goldman Sachs Group Inc | 2.94M | $92.06M | −59.6K | Reduced |
| 7 | Blackrock, Inc. | 2.51M | $78.41M | +74.1K | Added |
| 8 | Sofinnova Investments, Inc. | 1.90M | $59.59M | 0 | Held |
| 9 | Johnson & Johnson | 1.78M | $55.84M | 0 | Held |
| 10 | Polar Capital Holdings PLC | 1.64M | $51.39M | +637.7K | Added |
131 more institutional holders on Premium
See every fund holding Rapport Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders